ANTIFUNGAL SUSCEPTIBILITY TESTING
نویسندگان
چکیده
منابع مشابه
Antifungal susceptibility testing.
Antifungal susceptibility testing has been in routine use now for more than 15 years and has become a useful tool for clinicians who are faced with difficult treatment decision. Although most clinicians order susceptibility testing, much confusion still exists regarding the use of the results. Sufficient data have been generated to determine susceptibility trends for specific fungi against spec...
متن کاملPersonalized antifungal susceptibility testing.
Introduction In recent years, the remarkable increase in the number of infections caused by fungal pathogens, especially in immunocompromised people, has stimulated interest in medical mycology in general and in antifungal susceptibility testing in particular. 1,2 In-vitro procedures for determining the activity of drugs against mould and yeast isolates involve clinicians in the choice and moni...
متن کاملIssues in antifungal susceptibility testing.
In line with the availability of an increasing array of systemic antifungal agents, there is a need for accurate, reproducible and predictive susceptibility testing of fungal isolates in order to help inform clinical choice. Much early attention on antifungal susceptibility testing focused on defining test parameters that produced reproducible and reliable intra- and inter-laboratory results an...
متن کاملThe evolving role of antifungal susceptibility testing.
Although increasing numbers of hospital microbiology laboratories are performing antifungal susceptibility testing (AST), its routine use is uncommon. The utility of AST is founded on the belief that susceptibility (or resistance) of an agent allows some prediction of clinical outcome. This review provides an overview of the development of antifungal susceptibility testing methodology, includin...
متن کاملAntifungal Susceptibility Testing for Systemic Mycoses
Introduction Compared to antibacterial drugs, antimicrobial agents available for treatment of invasive fungal infections are sparse. Amphotericin B (polyene) was the first drug introduced in the 1950s, followed by flucytosine (pyrimidine) in the 1970s, and first-generations azoles (fluconazole, itraconazole) in the 1990s. Triazoles (voriconazole, posaconalzole) and echinocandins (caspofungin, m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Infectious Disease Clinics of North America
سال: 1993
ISSN: 0891-5520
DOI: 10.1016/s0891-5520(20)30531-6